These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38558459)

  • 1. Evaluation of the relationship between serum eosinophil and D-dimer levels and demographic and clinical characteristics in bullous pemphigoid patients.
    Oktem A; Erkanoglu GL; Akay BN
    J Eur Acad Dermatol Venereol; 2024 Apr; ():. PubMed ID: 38558459
    [No Abstract]   [Full Text] [Related]  

  • 2. Skin Eosinophil Counts in Bullous Pemphigoid as a Prognostic Factor for Disease Severity and Treatment Response.
    Baum S; Engler Markowitz M; Lyakhovitsky A; Gershon R; Aviv H; Segal Z; Barzilai A
    Acta Derm Venereol; 2023 Jan; 103():adv00850. PubMed ID: 36250732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of D-dimer and fibrin degradation products correlate with bullous pemphigoid severity: a cross-sectional study.
    Wang S; Lu M; Zhao Z; Peng X; Li L; Cheng C; Fang M; Xia Y; Liu Y
    Sci Rep; 2021 Sep; 11(1):17746. PubMed ID: 34493780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue eosinophil levels as a marker of disease severity in bullous pemphigoid.
    Gore Karaali M; Koku Aksu AE; Cin M; Leblebici C; Kara Polat A; Gurel MS
    Australas J Dermatol; 2021 May; 62(2):e236-e241. PubMed ID: 33748980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum eosinophil cationic protein (ECP) in bullous pemphigoid.
    Caproni M; Palleschi GM; Falcos D; D'Agata A; Cappelli G; Fabbri P
    Int J Dermatol; 1995 Mar; 34(3):177-80. PubMed ID: 7751092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of patients with bullous pemphigoid: comparison of classic bullous pemphigoid to non-bullous pemphigoid.
    Ben Mordehai Y; Faibish H; Astman N; Greenberger S; Barzilai A; Baum S
    J Eur Acad Dermatol Venereol; 2020 Jan; 34(1):161-165. PubMed ID: 31423677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocyte activation in bullous diseases: release of granular proteins in bullous pemphigoid and pemphigus vulgaris.
    Czech W; Schaller J; Schöpf E; Kapp A
    J Am Acad Dermatol; 1993 Aug; 29(2 Pt 1):210-5. PubMed ID: 8393016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulator Galectin-9 is Increased in Blood and Skin of Patients with Bullous Pemphigoid.
    Pruessmann J; Pruessmann W; Holtsche MM; Linnemann B; Hammers CM; van Beek N; Zillikens D; Schmidt E; Sadik CD
    Acta Derm Venereol; 2021 Mar; 101(3):adv00419. PubMed ID: 33606034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophil cationic protein levels parallel coagulation activation in the blister fluid of patients with bullous pemphigoid.
    Tedeschi A; Marzano AV; Lorini M; Balice Y; Cugno M
    J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):813-7. PubMed ID: 24650303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophil-colony stimulating activity in blister fluid of bullous pemphigoid.
    Kawachi Y; Otsuka F
    J Dermatol Sci; 1997 May; 15(1):51-4. PubMed ID: 9186812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Peripheral Blood and Cutaneous Eosinophils With Bullous Pemphigoid Disease Severity and Treatment Outcomes.
    Garrido PM; Aguado-Lobo M; Espinosa-Lara P; Soares-Almeida L; Filipe P
    Actas Dermosifiliogr; 2022 Oct; 113(9):881-887. PubMed ID: 35659610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid Disease Control in First-Line Therapy-Resistant Mucous Membrane Pemphigoid and Bullous Pemphigoid with Omalizumab as Add-On Therapy: A Case Series Of 13 Patients.
    Alexandre M; Bohelay G; Gille T; Le Roux-Villet C; Soued I; Morin F; Caux F; Grootenboer-Mignot S; Prost-Squarcioni C
    Front Immunol; 2022; 13():874108. PubMed ID: 35514989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basement membrane zone IgE deposition is associated with bullous pemphigoid disease severity and treatment results.
    Kamata A; Kurihara Y; Funakoshi T; Takahashi H; Kuroda K; Hachiya T; Amagai M; Yamagami J
    Br J Dermatol; 2020 May; 182(5):1221-1227. PubMed ID: 31330562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between clinical findings of patients with bullous pemphigoid and antigens recognized by their circulating antibasement membrane zone antibodies].
    Gary A; Carvalho P; Louison JB; Helot MF; Gilbert D; Bernard P; Roujeau JC; Bedane C; Delaporte E; Vaillant L; Dreno B; Saiag P; Tancrede-Bohin E; Plantin P; D'Incan M; Sassolas B; Lok C; Labeille B; Pauwels C; Chosidow O; Picard C; Loche F; Guillaume JC; Joly P
    Ann Dermatol Venereol; 2004 Apr; 131(4):333-7. PubMed ID: 15258506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of specific histologic changes in guinea pig skin treated with bullous pemphigoid antibodies.
    Gammon WR; Briggaman RA
    J Invest Dermatol; 1988 Apr; 90(4):495-500. PubMed ID: 3280699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eosinophil Cationic Protein (ECP), a predictive marker of bullous pemphigoid severity and outcome.
    Giusti D; Gatouillat G; Le Jan S; Plée J; Bernard P; Antonicelli F; Pham BN
    Sci Rep; 2017 Jul; 7(1):4833. PubMed ID: 28684769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum soluble CD200 level was higher in patients with bullous pemphigoid during the active phase of the disease than for healthy individuals.
    Akman-Karakaş A; Yalcin AD; Koç S; Gumuslu S; Ergun E; Genc GE; Ongut G; Uzun S; Alpsoy E
    Clin Lab; 2014; 60(7):1237-40. PubMed ID: 25134396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of coagulation in bullous pemphigoid and other eosinophil-related inflammatory skin diseases.
    Marzano AV; Tedeschi A; Berti E; Fanoni D; Crosti C; Cugno M
    Clin Exp Immunol; 2011 Jul; 165(1):44-50. PubMed ID: 21488867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence, Spectrum and Clinical Implications of Malignancies in Patients with Bullous Pemphigoid.
    Baum S; Steinberg S; Tzanani I; Barzilai A; Lyakhovitsky A
    Acta Derm Venereol; 2023 Mar; 103():adv00888. PubMed ID: 36916952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum eosinophil chemotactic factor levels in patients with bullous pemphigoid, drug reactions and atopic eczema.
    Czarnetzki BM; Kalveram KJ; Dierksmeier U
    J Invest Dermatol; 1979 Aug; 73(2):163-5. PubMed ID: 156767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.